Daniel Weintraub

Trials

Studies that name Daniel Weintraub as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:55 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT06498349 · Bilateral Subthalamic Stimulation in PD Patients With Impulse Control Disorders - STIMPulseControl

  University of Kiel · recruiting · Parkinson Disease, Impulse Control Disorders · study chair
• Ph4
  NCT04373317 · Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis

  VA Office of Research and Development · recruiting · Parkinson's Disease Psychosis · study chair
• Ph4
  NCT01519271 · Mild Cognitive Impairment in Parkinson's Disease

  University of Pennsylvania · completed · Parkinson's Disease, Mild Cognitive Impairment · principal investigator
• Ph4
  NCT01052831 · Naltrexone for Impulse Control Disorders in Parkinson's Disease

  University of Pennsylvania · completed · Impulse Control Disorder, Parkinson Disease · principal investigator
• Ph3
  NCT01014858 · Multi-centre UK Study of the Acetylcholinesterase Inhibitor Donepezil in Early Dementia Associated With Parkinson's Disease

  Newcastle-upon-Tyne Hospitals NHS Trust · terminated · Parkinson's Disease · study director
• Ph3
  NCT00898807 · Citalopram for Agitation in Alzheimer's Disease

  JHSPH Center for Clinical Trials · completed · Alzheimer's Disease, Agitation · principal investigator
• Ph4
  NCT00304161 · Effectiveness of Antidepressant Treatment for Depression in People With Parkinson's Disease

  University of Pennsylvania · completed · Depressive Disorder, Parkinson Disease · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-11 23:55 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

• Core B: Clinical Core
  P01AG084497 · NIA · UNIVERSITY OF PENNSYLVANIA · fiscal years 2024 to 2026 · $549,593 awarded in 2026
  Same name and institution; not confirmed by an ID
• Clinical Core B
  U19AG062418 · NIA · UNIVERSITY OF PENNSYLVANIA · fiscal years 2019 to 2023 · $549,515 awarded in 2023
  Same name and institution; not confirmed by an ID
• Efficient statistical methods for assessing dementia risk in Parkinson's disease
  R01NS102324 · NINDS · UNIVERSITY OF PENNSYLVANIA · fiscal years 2017 to 2020 · $311,573 awarded in 2020
  Same name and institution; not confirmed by an ID
• CORE B: Clinical Core
  P50NS053488 · NINDS · UNIVERSITY OF PENNSYLVANIA · fiscal years 2017 · $349,552 awarded in 2017
  Same name and institution; not confirmed by an ID
• DEPRESSION DIAGNOSIS AND TREATMENT IN PARKINSON DISEASE
  K23MH067894 · NIMH · UNIVERSITY OF PENNSYLVANIA · fiscal years 2004 to 2008 · $179,740 awarded in 2008
  Grant number is on one of their registry trials
• Depression in Alzheimer's Disease Study-2(DIADS-2)
  U01MH066174 · NIMH · UNIVERSITY OF PENNSYLVANIA · fiscal years 2006 to 2007 · $73,721 awarded in 2007
  Same name and institution; not confirmed by an ID

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Citalopram Treatment for Agitation in Alzheimer Dementia
  R01AG031348 · NIA · JOHNS HOPKINS UNIVERSITY · PI CONSTANTINE G LYKETSOS · fiscal years 2008 to 2012
  Named on NCT00898807